### ğŸ« Pulmonary Medicine: Lung Cancer Screening

#### âœ… True Statements
1. **Annual low-dose computed tomography (CT)** has been shown to reduce **lung cancer mortality** with a **20% relative decrease in lung cancer deaths** among persons at high risk.  
2. The **U.S. Preventive Services Task Force (USPSTF)** recommends lung cancer screening for **patients aged 50 to 80 years** with at least a **20-pack-year history of tobacco use** who are **still active smokers** or who **quit smoking in the last 15 years**.  
3. The **American Cancer Society** recommends lung cancer screening for **patients aged 50 to 80 years** with at least a **20-pack-year history of tobacco use**, regardless of whether they **continue to smoke** or **when they quit**.  
4. **Chest radiography** is **ineffective** for lung cancer screening and is **not indicated** in asymptomatic patients.  
5. **Spirometry** should **not** be used to screen for lung disease in **asymptomatic patients**, even in those with a history of smoking.  
6. **Urinary cotinine testing** is **not indicated** for lung cancer screening, because smoking history alone determines screening eligibility.  
7. Patients eligible for **low-dose CT lung cancer screening** must also receive **in-office counseling** regarding potential **benefits and harms**, with **documentation of shared decision making**.

#### ğŸ·ï¸ Tags
#PulmonaryMedicine #LungCancer #Screening #CT #USPSTF #AmericanCancerSociety #Smoking

#### ğŸ“š Reference
Wolf AMD, Oeffinger KC, Shih TY, et al. Screening for lung cancer: 2023 guideline update from the American Cancer Society. *CA Cancer J Clin*. 2024;74:50-81. PMID: 37909877 doi:10.3322/caac.21811  

#### ğŸ†” Question ID
PMQQQ24012  

#### ğŸ•’ Last Updated
February 2025  

---

#### ğŸ“– Related Text
MKSAP 19: Pulmonary Medicine â€” Lung Tumors, Lung Cancer, Lung Cancer Screening

---

### ğŸ“˜ Related Text Derivations

#### âœ… True Statements â€” Lung Cancer Screening
1. Before 2013, lung cancer screening was **not widely performed** because earlier studies failed to show a **mortality benefit**.  
2. The **National Lung Screening Trial** demonstrated a **20% reduction in lung cancer mortality** in patients with a **â‰¥30 pack-year smoking history** who underwent **annual screening for 3 years**.  
3. The **USPSTF** recommends **annual lung cancer screening** with **low-dose CT** in **high-risk patients** (grade B recommendation).  
4. Lung cancer screening should be performed in **patients aged 50 to 80 years** who have **no symptoms of lung cancer** and a **â‰¥20 pack-year smoking history**.  
5. The **USPSTF** recommends **cessation of screening** once a patient has **not smoked for 15 years**, or if they have a **limited life expectancy** or are **not candidates for or unwilling to undergo surgery**.  
6. In contrast, the **American Cancer Society** recommends screening **all patients** with a **smoking history** who meet age and pack-year criteria, regardless of **time since quitting**.

#### ğŸ·ï¸ Tags
#PulmonaryMedicine #LungCancer #Screening #USPSTF #AmericanCancerSociety #Smoking #NationalLungScreeningTrial
